K. Maejima et al., Increased basal levels of plasma nitric oxide in Type 2 diabetic subjects - Relationship to microvascular complications, J DIABET C, 15(3), 2001, pp. 135-143
To assess the underlying mechanisms of decreased endothelial function and a
dvanced vascular complications in patients with Type 2 diabetes, we determi
ned basal levels of plasma nitric oxide (NOx: NO2 (-) and NO3 (-)) using a
newly developed high-performance liquid chromatography (HPLC)-Griess method
in hospitalized 129 diabetic and 76 nondiabetic subjects, and examined the
ir clinical characteristics. Serum lipid peroxide and advanced glycation en
d products (AGEs) as markers of oxidative stress were also measured, and in
tima-media thickness (IMT) of the carotid artery was evaluated as a marker
of atherosclerosis. In diabetic subjects, microvascular complications were
newly evaluated during their admission. There were no differences in age or
sex between the diabetic and nondiabetic subjects. Although there was no d
ifference in basal plasma NO2 (-) levels between the two groups, the basal
levels of plasma NO3 (-) in diabetic subjects were significantly higher tha
n those in nondiabetic subjects. Plasma NOx levels in neither diabetic nor
nondiabetic subjects correlated with serum lipids, HbAlc, or IMT. In diabet
ic subjects, plasma NO3 (-) levels were related not only to the presence of
hypertension but also to advanced microvascular complications. Moreover, p
lasma NO3 (-) levels were positively correlated with both serum lipid perox
ide and AGEs. Multiple regression analysis revealed that serum AGEs level w
as strongly associated with plasma NO3 (-) level. Thus, the findings are co
nsistent with the hypothesis that decreased endothelium-dependent vasodilat
ion in diabetic subjects is associated with the impaired action of NO secon
dary to its inactivation resulting from increased oxidative stress, rather
than decreased NO production from vascular endothelium, and that abnormal N
O metabolism is related to advanced diabetic microvascular complications. (
C) 2001 Elsevier Science Inc. All rights reserved.